David Rosen, a partner and member of the Life Sciences and Nanotechnology Industry Teams, will be moderating a panel for the Tech Council of Maryland entitled, “Nanomedicine, Opportunities and Challenges.” The session will be taking place at John Hopkins University on September 12, 2007.
The panel will discuss the promises as well as some of the challenges are to creating these new therapies that may be safer and more effective in treating life-threatening diseases.
Deelnemers aan het panel zijn onder meer:
- Dr. Hamid Ghandehari, Director, University of Maryland School of Pharmacy, Center for Nanomedicine and Cellular Delivery, Department of Pharmaceutical Sciences
- Dr. Chiming Wei, Department of Surgery, The Johns Hopkins School of Medicine and President, American Academy of Nanomedicine
- Dr. Lawrence Tamarkin, President & CEO, CytImmune Sciences, Inc.
Mensen
Verwante inzichten
December 12, 2025
Health Care Law Today
Eleventh Circuit Hears Oral Argument in Landmark Constitutional Challenge to False Claims Act’s Qui Tam Provisions
On December 12, the U.S. Court of Appeals for the Eleventh Circuit heard oral argument in U.S. ex rel. Zafirov v. Florida Medical…
11 december 2025
Foley Standpunten
Antitrustrisico's en nalevingsstrategieën bij het beheer van intellectuele-eigendomsportfolio's
Dit artikel analyseert hoe het beheer van intellectuele-eigendomsportfolio's tegelijkertijd innovatie kan bevorderen en potentieel kan bieden...
11 december 2025
Foley Standpunten
CARB publiceert voorgestelde regelgeving voor SB 261 en 253
Op 9 december 2025 heeft de California Air Resources Board (CARB) haar voorgestelde regelgevingstekst voor de eerste regelgeving gepubliceerd...